Stocks That Hit 52-Week Highs On Monday
Monday's session saw 22 companies set new 52-week highs.
Stocks That Hit 52-Week Lows On Tuesday
During Tuesday's session, 454 stocks hit new 52-week lows.
Neovasc Q4 EPS $(0.09) Beats $(0.10) Estimate, Sales $759.12K Miss $800.00K Estimate
Neovasc (NASDAQ:NVCN) reported quarterly losses of $(0.09) per share which beat the analyst consensus estimate of $(0.10) by 10 percent. This is a 50 percent increase over losses of $(0.18) per share from the same period
The Week Ahead In Biotech (March 6-12): Quiet Week On Tap With Earnings Season Reaching It Final Leg
Biotech stocks reversed course in the week ending March 4, as the Ukrainian crisis weighed down on the broader market as well as the sector. The iShares Biotechnology ETF (NASDAQ: IBB) retreated in four out of five sessions of the week.
Neovasc Announces German Reimbursement Renewal
via NewMediaWire -- Neovasc, Inc. (Neovasc or the Company) (NASDAQ, TSX: NVCN) today announced the German Institute for the Hospital Remuneration System ("InEK") has awarded the Neovasc
Neovasc Highlights Independent Publication On Co’s Reducer
- Neovasc, Inc. (Neovasc or the Company) (NASDAQ, TSX: NVCN) today announced the publication of cost-effectiveness studies supporting the use of the Neovasc Reducer™
Neovasc Announces Complete Dismissal Of Securities Class Action Complaint With Prejudice
Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ:NVCN) (TSX:NVCN), today announced the complete dismissal of the consolidated amended complaint in the shareholder class action case
Neovasc Shares Spike Higher; Neovask Reducer System Receives National Reimbursement In France
Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN) today announced that the Neovasc Reducer™ ("Reducer") system has been granted Prise en Charge